Edge Therapeutics Inc (NASDAQ:EDGE) saw strong trading volume on Friday . 6,794,166 shares were traded during mid-day trading, an increase of 751% from the previous session’s volume of 798,418 shares.The stock last traded at $0.68 and had previously closed at $0.57.
Separately, ValuEngine raised Edge Therapeutics from a “hold” rating to a “buy” rating in a report on Thursday, November 1st. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. Edge Therapeutics currently has an average rating of “Hold” and an average price target of $17.00.
Edge Therapeutics (NASDAQ:EDGE) last posted its earnings results on Thursday, November 1st. The biotechnology company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.16.
ILLEGAL ACTIVITY WARNING: This story was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.com-unik.info/2018/11/30/edge-therapeutics-edge-sees-strong-trading-volume.html.
Edge Therapeutics Company Profile (NASDAQ:EDGE)
Edge Therapeutics, Inc, a clinical-stage biotechnology company, discovers, develops, and seeks to commercialize hospital-based therapies for acute life-threatening neurological and other conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage.
See Also: Understanding Average Daily Trade Volume
Receive News & Ratings for Edge Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edge Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.